FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology Annual Meeting

1d ago

FGEN

PremiumPress Releases

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

23d ago

FGEN

PremiumPress Releases

FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference

1M ago

FGEN

PremiumPress Releases

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer

2M ago

FGEN

PremiumPress Releases

FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results

2M ago

FGEN

PremiumPre-Earnings

FGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

2M ago

FGEN

PremiumPress Releases

FibroGen to Report Fourth Quarter and Full Year 2023 Financial Results

2M ago

FGEN

More FGEN News >

FGEN News on the Web

2024-04-23

Vertex , TreeFrog Sign Deal for Diabetes Cell Therapies

Yahoo Finance

Neutral

2024-04-23

Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies

Zacks

Neutral

2024-04-22

Here's Why You Should Add Immunovant (IMVT) to Your Portfolio

Zacks

Neutral

2024-04-19

Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug

Zacks

Neutral

2024-04-19

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study

Zacks

Neutral

2024-04-18

DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch

Zacks

Neutral

2024-04-17

Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals

Zacks

Neutral

2024-04-16

Ultragenyx Meets Efficacy Goal in Neuro Disease Study

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

FGEN

Sector Average

Media Buzz

This Week5 articles

Weekly Average6.5 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FGEN’s Media Buzz Sentiment?

5 articles about FGEN were published this week. In an average week, 6.5 articles are published.

What is FGEN’s weekly average amount of articles?

In an average week, 6.5 articles about FGEN are published.

What is FGEN’s News Sentiment?

50% of articles about FGEN were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

NBIXNeurocrine

AMEDAmedisys

HSTMHealthStream

IMVTImmunovant

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing